An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Clinical trial NCT07469683 · RECRUITING

Trial details

NCT number: NCT07469683
Sponsor: Yonsei University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Neoplasms Malignant Neoplasms Malignant Neoplasm of Kidney, Except Renal Pelvis

Start date: 2026-03-01
Primary completion: 2029-10-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.